Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    October 2021
  1. HANDA Y, Tsutani Y, Okada M
    Reply to "Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?" by Han-Yu Deng.
    Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10684.
    PubMed    


  2. SHI Y, Wu S, Ma S, Lyu Y, et al
    Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
    Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10857.
    PubMed     Abstract available


  3. ZHU Y, Xia L, Liu C, Lin F, et al
    Uniportal Single-Direction Thoracoscopic Right S9 Segmentectomy: Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2021;28:6407.
    PubMed     Abstract available


  4. NISHINO T, Toba H, Yoshida T, Inoue S, et al
    Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer.
    Ann Surg Oncol. 2021;28:6398-6406.
    PubMed     Abstract available


  5. LEPPELMANN KS, Levesque VM, Bunck AC, Cahalane AM, et al
    Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
    Ann Surg Oncol. 2021;28:5829-5839.
    PubMed     Abstract available


  6. LI S, Qiao S, Li N, Zhu X, et al
    MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10688.
    PubMed     Abstract available


    September 2021
  7. WEI X, Yu H, Dai W, Mu Y, et al
    Correction to: Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10798.
    PubMed    


  8. HANDA Y, Tsutani Y, Okada M
    ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection.
    Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10037.
    PubMed    


    August 2021
  9. DENG HY
    Lobe-Specific Lymph Node Dissection for Lung Cancer: Is it Still Feasible?
    Ann Surg Oncol. 2021 Aug 21. pii: 10.1245/s10434-021-10671.
    PubMed    


  10. WANG C, Wang S, Li Z, He W, et al
    ASO Visual Abstract: A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Aug 3. pii: 10.1245/s10434-021-10542.
    PubMed    


  11. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4542-4550.
    PubMed     Abstract available


  12. ZHAO ZR, Long H
    ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4551-4552.
    PubMed    


    July 2021
  13. WANG C, Wang S, Li Z, He W, et al
    A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Jul 28. pii: 10.1245/s10434-021-10504.
    PubMed     Abstract available


  14. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
    Ann Surg Oncol. 2021 Jul 3. pii: 10.1245/s10434-021-10020.
    PubMed     Abstract available


  15. FU X, Wang F, Su X, Luo G, et al
    Endobronchial Ultrasound Improves Evaluation of Recurrent Laryngeal Nerve Lymph Nodes in Esophageal Squamous Cell Carcinoma Patients.
    Ann Surg Oncol. 2021;28:3930-3938.
    PubMed     Abstract available


  16. KIM IA, Hur JY, Kim HJ, Park JH, et al
    Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3983-3993.
    PubMed     Abstract available


  17. KIM IA, Kim WS, Lee KY
    ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3994-3995.
    PubMed    


    June 2021
  18. CHIANG XH, Lin MW, Hsu HH, Chen JS, et al
    ASO Author Reflection: Comparing Wedge Resection and Segmentectomy as the Appropriate Surgical Method in cT1N0 Lung Cancer.
    Ann Surg Oncol. 2021 Jun 5. pii: 10.1245/s10434-021-10214.
    PubMed    


  19. NAKAMURA A, Kondo N, Nakamichi T, Hashimoto M, et al
    Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2021;28:3057-3065.
    PubMed     Abstract available


  20. MATSUBARA T, Okamoto T
    ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.
    Ann Surg Oncol. 2021;28:3055-3056.
    PubMed    


    May 2021
  21. WEI X, Yu H, Shi Q
    ASO Author Reflections: Using Patient-Reported Outcomes to Evaluate Surgical Approaches for Locally Advanced Lung Cancer.
    Ann Surg Oncol. 2021 May 15. pii: 10.1245/s10434-021-10018.
    PubMed    


  22. LOTZE MT, Dhupar R
    ASO Author Reflection: Viruses, the Lung, and Thoracic Neoplasms: Breaking Bad.
    Ann Surg Oncol. 2021;28:2728-2729.
    PubMed    


    April 2021
  23. MIMAE T, Saji H, Nakamura H, Okumura N, et al
    Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
    Ann Surg Oncol. 2021 Apr 26. pii: 10.1245/s10434-021-09835.
    PubMed     Abstract available


  24. WEI X, Yu H, Dai W, Mu Y, et al
    Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Apr 20. pii: 10.1245/s10434-021-09981.
    PubMed     Abstract available


  25. GOOSEMAN MR, Brunelli A
    Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery.
    Ann Surg Oncol. 2021 Apr 16. pii: 10.1245/s10434-021-10039.
    PubMed    


  26. KANTOR T, Wakeam E
    Landmark Trials in the Surgical Management of Mesothelioma.
    Ann Surg Oncol. 2021;28:2037-2047.
    PubMed     Abstract available


  27. CHEN D, Ding Q, Wang W, Wang X, et al
    Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2088-2098.
    PubMed     Abstract available


  28. KAGIMOTO A, Tsutani Y, Okada M
    ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
    Ann Surg Oncol. 2021;28:2076-2077.
    PubMed    


  29. KAGIMOTO A, Tsutani Y, Handa Y, Mimae T, et al
    Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2068-2075.
    PubMed     Abstract available


    March 2021
  30. MIMAE T, Saji H, Okada M
    ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?
    Ann Surg Oncol. 2021 Mar 23. pii: 10.1245/s10434-021-09860.
    PubMed    


  31. ZENG Q, Li J, Tan F, Sun N, et al
    Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Mar 2. pii: 10.1245/s10434-020-09552.
    PubMed     Abstract available


    February 2021
  32. TSUDAKA S, Yamamoto H, Sato H, Toyooka S, et al
    ASO Author Reflections: Impact of the Postoperative Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small Cell Lung Cancer Treated with Induction Chemoradiotherapy Followed by Surgery.
    Ann Surg Oncol. 2021 Feb 25. pii: 10.1245/s10434-021-09699.
    PubMed    


  33. TSUDAKA S, Yamamoto H, Sato H, Katsui K, et al
    Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy.
    Ann Surg Oncol. 2021 Feb 25. pii: 10.1245/s10434-021-09690.
    PubMed     Abstract available


  34. BATCHELOR T, Hasan J, Macbeth F, Shackcloth M, et al
    Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer.
    Ann Surg Oncol. 2021 Feb 15. pii: 10.1245/s10434-020-09521.
    PubMed     Abstract available


  35. VAN VEENENDAAL LM, Bertolli E, Korse CM, Klop WMC, et al
    The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
    Ann Surg Oncol. 2021;28:1019-1028.
    PubMed     Abstract available


    January 2021
  36. LI S, Wu N
    ASO Author Reflections: Proposed Nodal Categories for Future Editions of the TNM Classification of Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Jan 9. pii: 10.1245/s10434-020-09516.
    PubMed    


  37. LI S, Yan S, Lu F, Lv C, et al
    Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Jan 2. pii: 10.1245/s10434-020-09461.
    PubMed     Abstract available


  38. SHIGEFUKU S, Shimada Y, Hagiwara M, Kakihana M, et al
    Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:148-156.
    PubMed     Abstract available


  39. SHIGEFUKU S, Shimada Y
    ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:157-158.
    PubMed    


  40. OHTSUKA T
    Importance of Ground-Glass Opacity in Long-Term Survivors of Lung Adenocarcinoma: A Leopard Cannot Change Its Spots.
    Ann Surg Oncol. 2021;28:14-15.
    PubMed    


    December 2020
  41. LEINWAND JC, Kluger MD
    ASO Author Reflections: Improving Outcomes in Diffuse Malignant Peritoneal Mesothelioma: Challenges and Opportunities.
    Ann Surg Oncol. 2020;27.
    PubMed    


    November 2020
  42. ZUO Z, Zhang G, Song P, Yang J, et al
    Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Ann Surg Oncol. 2020 Nov 28. pii: 10.1245/s10434-020-09362.
    PubMed     Abstract available


  43. YAMAMOTO H, Yamamoto H, Soh J, Suzuki E, et al
    A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
    Ann Surg Oncol. 2020 Nov 24. pii: 10.1245/s10434-020-09272.
    PubMed     Abstract available


  44. YAMAMOTO H, Yamamoto H, Toyooka S
    A New Scoring System for Predicting the Survival of Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
    Ann Surg Oncol. 2020 Nov 4. pii: 10.1245/s10434-020-09299.
    PubMed    


    October 2020
  45. EBY M, Seder CW
    Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al.
    Ann Surg Oncol. 2020 Oct 26. pii: 10.1245/s10434-020-09258.
    PubMed    


  46. KUMAR N, Bhoriwal S, Kumar S
    Letter to the Editor of Annals of Surgical Oncology Concerning "The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer".
    Ann Surg Oncol. 2020 Oct 22. pii: 10.1245/s10434-020-09249.
    PubMed    


  47. MATSUBARA T, Takamori S, Haratake N, Fujishita T, et al
    Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Oct 21. pii: 10.1245/s10434-020-09230.
    PubMed     Abstract available


  48. KANZAKI R
    ASO Author Reflections: Long-Term Outcomes of Pulmonary Metastasectomy for Uterine Malignancies: A Multi-institutional Study in the Current Era.
    Ann Surg Oncol. 2020;27:3829-3830.
    PubMed    


  49. TANG WF, Zhong WZ
    ASO Author Reflections: Lung Adenocarcinoma with Accidental Invisible Pleural Dissemination Lesions: Wait-and-See Strategy for Tumors with Indolent Biologic Characteristics.
    Ann Surg Oncol. 2020;27:3819-3820.
    PubMed    


  50. JUNG W, Cho S, Yum S, Chung JH, et al
    Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces.
    Ann Surg Oncol. 2020;27:4394-4403.
    PubMed     Abstract available


  51. TSAI PC, Yeh YC, Hsu PK, Chen CK, et al
    CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:4405-4412.
    PubMed     Abstract available


  52. DEMMY TL
    The Musician, Instrument, or Orchestra?
    Ann Surg Oncol. 2020;27:4088-4090.
    PubMed    


  53. JUNG W, Cho S
    ASO Author Reflections: Understanding Subsolid Lung Adenocarcinoma with Cystic Airspaces (LACA).
    Ann Surg Oncol. 2020;27:4404.
    PubMed    


    September 2020
  54. CHEN D, Ding Q, Wang W, Chen C, et al
    ASO Author Reflections: Old Song, New Sung-Extracapsular Extension in Lung Cancer in the Era of Eighth-Edition N Classification.
    Ann Surg Oncol. 2020 Sep 22. pii: 10.1245/s10434-020-09173.
    PubMed    


  55. WANKHEDE D
    Evaluation of Eighth AJCC TNM Sage for Lung Cancer NSCLC: A Meta-analysis.
    Ann Surg Oncol. 2020 Sep 20. pii: 10.1245/s10434-020-09151.
    PubMed     Abstract available


  56. CHEN Y, Zhang J, Chen L, Dai J, et al
    Lymph Node Examination for Stage I Second Primary Lung Cancer Patients Who Received Second Surgical Treatment.
    Ann Surg Oncol. 2020 Sep 5. pii: 10.1245/s10434-020-08975.
    PubMed     Abstract available


    August 2020
  57. ZHU Y, Liu L
    ASO Author Reflections: A Novel Concept to Decreasing the Technical Difficulty of Complex Pulmonary Segmentectomy.
    Ann Surg Oncol. 2020;27:3094-3095.
    PubMed    


    July 2020
  58. MASCALCHI M
    Lung Cancer Associated with Cystic Airspaces in the Screening Perspective.
    Ann Surg Oncol. 2020 Jul 22. pii: 10.1245/s10434-020-08929.
    PubMed    


  59. LIU C, Wei S, Liu L
    ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node.
    Ann Surg Oncol. 2020 Jul 20. pii: 10.1245/s10434-020-08876.
    PubMed    


  60. TAKAMORI S, Shimokawa M, Matsubara T, Haratake N, et al
    Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Jul 16. pii: 10.1245/s10434-020-08851.
    PubMed     Abstract available


  61. YANG Y, Mei J, Lin F, Pu Q, et al
    Comparison of the Short- and Long-term Outcomes of Video-assisted Thoracoscopic Surgery versus Open Thoracotomy Bronchial Sleeve Lobectomy for Central Lung Cancer: A Retrospective Propensity Score Matched Cohort Study.
    Ann Surg Oncol. 2020 Jul 8. pii: 10.1245/s10434-020-08805.
    PubMed     Abstract available


  62. TAKAMORI S, Okamoto T, Mori M
    ASO Author Reflections: Which of Smoking Duration or Smoking Intensity Contributes to Poor Prognosis After Resection of Non-small Cell Lung Cancer?
    Ann Surg Oncol. 2020 Jul 8. pii: 10.1245/s10434-020-08852.
    PubMed    


  63. LIU C, Wei S, Guo C, Mei J, et al
    Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
    Ann Surg Oncol. 2020 Jul 7. pii: 10.1245/s10434-020-08786.
    PubMed     Abstract available


    June 2020
  64. ZHANG Y, Li G, Li Y, Liu Q, et al
    Imaging Features Suggestive of Multiple Primary Lung Adenocarcinomas.
    Ann Surg Oncol. 2020;27:2061-2070.
    PubMed     Abstract available


  65. WANG C, Yang J, Lu M
    Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy.
    Ann Surg Oncol. 2020;27:2051-2060.
    PubMed     Abstract available


  66. KINOSHITA F, Takada K, Yamada Y, Oku Y, et al
    Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:2102-2109.
    PubMed     Abstract available


    May 2020
  67. EBY ME, Seder CW
    The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2020 May 9. pii: 10.1245/s10434-020-08553.
    PubMed    


  68. BEKHOR E, Carr J, Hofstedt M, Sullivan B, et al
    The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis.
    Ann Surg Oncol. 2020;27:1448-1455.
    PubMed     Abstract available


    April 2020
  69. ZHANG X, Moriwaki T, Kawabata T, Goto S, et al
    Nicaraven Attenuates Postoperative Systemic Inflammatory Responses-Induced Tumor Metastasis.
    Ann Surg Oncol. 2020;27:1068-1074.
    PubMed     Abstract available


    March 2020
  70. CHIANG XH, Hsu HH, Hsieh MS, Chang CH, et al
    Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:703-715.
    PubMed     Abstract available


  71. CHIANG XH, Lin MW, Chen JS
    Indication for Sublobar Resection in cT1N0 Lung Adenocarcinoma is Contentious.
    Ann Surg Oncol. 2020;27:956-957.
    PubMed    


  72. KISHI N, Ito M, Miyata Y, Kanai A, et al
    Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component.
    Ann Surg Oncol. 2020;27:945-955.
    PubMed     Abstract available


  73. LIN MW, Chen JS
    ASO Author Reflections: Sublobar Resection En Route to Becoming the Standard of Care for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2020;27:716-717.
    PubMed    


    February 2020
  74. BOEDING JRE, Schreinemakers JMJ
    ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Ann Surg Oncol. 2020 Feb 11. pii: 10.1245/s10434-020-08250.
    PubMed    


    January 2020
  75. LETICA-KRIEGEL AS, Leinwand JC, Sonett JR, Gorenstein LA, et al
    50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
    Ann Surg Oncol. 2020;27:205-213.
    PubMed     Abstract available


    December 2019
  76. BROUWER NPM, van der Kruijssen DEW, Hugen N, de Hingh IHJT, et al
    The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.
    Ann Surg Oncol. 2019 Dec 2. pii: 10.1245/s10434-019-08100.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: